Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benyam Muluneh

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
Enhancing the Design and Evaluation of Care Delivery for Patients on Oral Anticancer AgentsBenyam Muluneh
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2021
Virtues of RuthBenyam Muluneh
Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2021
Financial Toxicity in Patients With Cancer: What a Tangled Web We WeaveBenyam Muluneh
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 26, 2023
Combined use of pembrolizumab and lenvatinib: A reviewCasey Eisinger, Benyam Muluneh
Expert Review of Clinical Pharmacology|April 17, 2024
Treatment adherence and adverse event management in chronic lymphocytic leukemia: challenges and strategies for the futureMaurlia D Upchurch, Benyam Muluneh
Clinical Journal of Oncology Nursing|March 21, 2024
Targeted Drug Therapies: Beyond Blood Counts and ChemistriesSolomea Asfaw, Samantha Matys, Benyam Muluneh
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 27, 2022
Oral oncolytic treatment for chronic lymphocytic leukemiaVincent Harris, Jared Borlagdan, Benyam Muluneh
Expert Review of Clinical Pharmacology|September 9, 2025
Oral oncolytic therapy adherence: can we shift patient behaviors and attitudes?Solomon Ayehu, Bethel Belayneh, Benyam Muluneh
Pharmacotherapy|February 26, 2013
Vemurafenib-associated pancreatitis: case reportBenyam Muluneh, Larry W Buie, Frances Collichio
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 18, 2023
Evaluation of real-world versus clinical trial outcomes of tyrosine kinase inhibitor therapy for chronic myeloid leukemiaJames B Collins, Benyam Muluneh, Sarah Profitt
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Journal of the National Comprehensive Cancer Network : JNCCN|October 14, 2022
Enhancing the Design and Evaluation of Care Delivery for Patients on Oral Anticancer AgentsBenyam Muluneh
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2021
Virtues of RuthBenyam Muluneh
Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2021
Financial Toxicity in Patients With Cancer: What a Tangled Web We WeaveBenyam Muluneh
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 26, 2023
Combined use of pembrolizumab and lenvatinib: A reviewCasey Eisinger, Benyam Muluneh
Expert Review of Clinical Pharmacology|April 17, 2024
Treatment adherence and adverse event management in chronic lymphocytic leukemia: challenges and strategies for the futureMaurlia D Upchurch, Benyam Muluneh
Clinical Journal of Oncology Nursing|March 21, 2024
Targeted Drug Therapies: Beyond Blood Counts and ChemistriesSolomea Asfaw, Samantha Matys, Benyam Muluneh
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 27, 2022
Oral oncolytic treatment for chronic lymphocytic leukemiaVincent Harris, Jared Borlagdan, Benyam Muluneh
Expert Review of Clinical Pharmacology|September 9, 2025
Oral oncolytic therapy adherence: can we shift patient behaviors and attitudes?Solomon Ayehu, Bethel Belayneh, Benyam Muluneh
Pharmacotherapy|February 26, 2013
Vemurafenib-associated pancreatitis: case reportBenyam Muluneh, Larry W Buie, Frances Collichio
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 18, 2023
Evaluation of real-world versus clinical trial outcomes of tyrosine kinase inhibitor therapy for chronic myeloid leukemiaJames B Collins, Benyam Muluneh, Sarah Profitt
Pageof 8